Table 1

 Detailed patient data

Case noAgeDuration (days from dx to sx)Dye usedStage @ SxSizeVA pre SxVA post SxSnellen lines changeLogMAR changeFollow up (months)Complications
Y, ILM peel done; ICG, indocyanine green; TB, trypan blue; Sx, surgery; Dx, diagnosis; PVR, proliferative vitreoretinopathy; MH, macular hole; RRD, rhegmatogenous retinal detachment.
Note: bold rows = patients not included in visual results analysis; For Snellen VA worse than 6/60, counting fingers = 1.2 and hand movement = 1.5.
Patient 17 had SF6 and all others had C3F8 gas.
17218550.50% ICG37001.51.50015
2 74 219 0.50% ICG 4 700 1 1 0 0 18 MH not closed
3773300.50% ICG3400110030
4 78 2974 0.50% ICG 3 400 0.78 1.2 −2 +0.42 11 Postoperative macular involving RRD (PVR)
5641380.50% ICG440010.6+2−0.4023
6641540.30% TB35000.780.18+4−0.6027
7713210.30% TB34000.780.18+4−0.6027
8641810.30% TB36000.780.3+3−0.4822
9562260.05% ICG22000.480.48001
10754160.05% ICG4500110026
1164100.30% TB42000.480.18+2−0.3025
12721190.05% ICG230010.6+2−0.402
13 64 122 0.05% ICG 4 700 0.78 0.6 +1 −0.18 24 ERM postoperatively, later ERM peel
14713950.05% ICG230010.48+3−0.5215Intraoperative RRD
15 68 202 0.05% ICG 3 400 1 1 0 0 2 MH not closed
16822830.05% ICG34001.20.3+5−0.903
17741050.05% ICG30.780.3+3−0.483
1880250.05% ICG23000.780.3+3−0.4812
19721100.05% ICG34000.60.3+2−0.309
20621650.05% ICG23000.60.3+2−0.302
2160670.05% ICG30.780.3+3−0.482Intraoperative RRD
22 73 510 0.30% TB 3 600 1 1.2 −1 −0.20 3 MH not closed
2381130.15% TB43000.480.18+2−0.304
24701240.15% TB35001.20.48+4−0.725
25711350.15% TB340010.3+4−0.701
26713460.15% TB230010.3+4−0.7013
27743650.15% TB350010.78+1−0.221
28732080.05% ICG220011006
29722400.15% TB360010.6+2−0.403
30671500.15% TB23001.20.3+5−0.902
31671650.15% TB370010.18+5−0.827
32 77 669 0.05% ICG in Healon 4 600 1.2 0.78 +3 −0.42 2
3367730.15% TB22000.30+2−0.306
34541030.15% TB22000.60.3+2−0.302
357617180.15% TB38000.780.78002
36 62 100 0.15% TB 3 400 0.6 1.5 −4 +0.9 4 Choroidal and vitreous haemorrhage
3765430.15% TB35001.20.30+5−0.903